In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

KellBenx gets antibodies from AdnaGen for use in prenatal diagnostics

Executive Summary

Alere Inc.’s AdnaGen AG division (biomarkers) has granted KellBenx Inc. (noninvasive prenatal diagnostics for genetic disorders) exclusive rights to antibodies that will be used in the extraction of clinical data from a sample of maternal blood.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register